Skip to main content
Signal8

Stuart Iain

SEC insider (Form 3/4/5 filer). CIK 0001727756. CHIEF SCIENTIFIC OFFICER at VYNE Therapeutics Inc. (VYNE). 10 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in STEWARTSVILLE, NJ.

Companies Stuart Iain has filed insider reports for

  • VYNE Therapeutics Inc. (VYNE): Officer, CHIEF SCIENTIFIC OFFICER
Stuart Iain profile photo

Stuart Iain

CIK: 0001727756

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (10.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (90.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VYNE Therapeutics Inc. logo
VYNE

VYNE Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jul 23, 2026
    Tax Payment
    Direct
    15.4K shares at avg. $0.90$14K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 30, 2026
    Tax Payment
    Direct
    2.4K shares at avg. $0.65$2K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Mar 31, 2026
    Tax Payment
    Direct
    2.9K shares at avg. $0.60$2K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Dec 31, 2025
    Tax Payment
    Direct
    2.4K shares at avg. $0.58$1K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Sep 30, 2025
    Tax Payment
    Direct
    2.5K shares at avg. $0.34$821.755
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jun 30, 2025
    Tax Payment
    Direct
    2.5K shares at avg. $1.65$4K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Mar 31, 2025
    Tax Payment
    Direct
    6K shares at avg. $1.58$10K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Jan 21, 2025
    Award

    Stock Option (right to buy)

    Direct
    230K shares-
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Dec 31, 2024
    Tax Payment
    Direct
    4.9K shares at avg. $3.35$16K
  • VYNE Therapeutics Inc. logo
    VYNE

    VYNE Therapeutics Inc.

    Sep 30, 2024
    Tax Payment
    Direct
    109 shares at avg. $1.88$204.92

1-10 of 10